No Detail Found!

Evaluating the Interplay between Pentraxin-3 and Cystatin C in Migraine Patients

Author(s)
Maham Tahir Department of Physiology, Islam Medical and Dental College,Sialkot,Pakistan
Mariyam Khan Nishtar Medical University,Multan,Pakistan
Mamoona Shafiq Department of Physiology, Islam Medical and Dental College,Sialkot,Pakistan
Adnan Ali Department of Physiology, Islam Medical and Dental College,Sialkot,Pakistan
Nayab Khalid Department of Physiology, Islam Medical and Dental College,Sialkot,Pakistan
Arooj Fatima Department of Physiology, Islam Medical and Dental College,Sialkot,Pakistan
Abstract
Objective: Evaluate the levels of serum pentraxin-3 and human cystatin C in migraine patients and the relationship between various parameters in migraine patients to healthy controls. Study Design: Cross-sectional comparative study. Place and Duration of Study: Department of Physiology, University of Lahore, Lahore Pakistan, from Apr 2021 to Apr 2022. Methodology: Following the collecting of histories, participants in the study - both cases and controls - were given a thorough clinical examination. A proforma was filled out by each candidate and a non-probability convenience sampling approach was chosen. After drawing blood samples, the serum was separated by centrifugation. The enzyme-linked immunosorbent assay (ELISA) was used to determine the concentrations of serum pentraxin-3 and cystatin C. Utilizing SPSS version 22, statistical analysis was conducted. The median IQR values of both groups were ascertained using the Mann-Whitney U test, with a pvalue of less than 0.05 being deemed significant. Results: Cases include 52.5% female patients and 47.5% male patients. Cases and controls had average ages of 25.57 5.93 and 26.15 7.19 respectively. BMI falls in the category 18-25 in most cases. Photophobia was the most common symptom, which was followed by phonophobia, nausea and vomiting. When comparing cases to controls, the mean cystatin C and pentraxin-3 levels were much higher in patients. Mean value of PTX-3 was 145.57±157.7 pg/l in cases and 43.65±33.01 pg/l in controls. Mean value of cystatin C was 0.97±0.67 mg/l in cases and 0.60±0.44 mg/l in controls. Conclusion: Levels of serum pentraxin-3 and human cystatin C were raised in migraine cases as compare to control group.
Publication Details
Page(s) 1526-1530
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 73, Issue: 5, Year: 2023

Request the full text from PASTIC

Keywords
Migraine, Cystatin C, Neuroinflammation, Antioxidant., Pentraxin-3, Neuroprotection
0

Citations

0

Downloads

91

Views